Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Warfarin Initiation at 3mg Versus 5mg for Anticoagulation of Mechanical Mitral Valve Replacement Patients

NCT04235569 is registered in ClinicalTrials.gov with Sarah Sabry Hashem as lead sponsor.

NCT NCT04235569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04235569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Warfarin Initiation at 3mg Versus 5mg for Anticoagulation of Mechanical Mitral Valve Replacement Patients
Lead sponsor
Sarah Sabry Hashem
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2018
Completion date
September 1, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve disease